There is good news and bad news on Thoratec Corporation (NASDAQ: THOR) today. The bad news is that it did have a FDA news recall of its HeartMate II® Left Ventricular ... Read Full Story »
Thoratec Corporation (NASDAQ: THOR) took it on the chin today after news came out about the Food & Drug Administration recalling the company's HeartMate II as the left ventricular-assist system. What is interesting ... Read Full Story »